News
Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how ...
They want to gain a deeper understanding of why the disease behaves differently in these patients. Read more at ...
Two years ago, Grafton learned he had stage 4 lung cancer. But thanks to a clinical trial at Duke funded by the National ...
Although the respiratory system is one of the main entry points for microplastics and nanoplastics (MNPs) from the air into ...
In a candid interview with CURE, Terry Gillespie reflects on how her definition of survivorship has evolved from her lung ...
Robert Kratzke, MD, urged insurance providers to prioritize fast biomarker testing in non–small cell lung cancer, saying it’s ...
2d
News-Medical.Net on MSNNew nanobody-liposome combo stops lung cancer growth and delivers targeted chemotherapyResearchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...
A new study out of the University of Minnesota's Hormel Institute looked at how dopamine can play a role in treating lung cancer. The study, published in the journal Cell Death & Disease, focused on ...
Small cell lung cancer (SCLC), one of the deadliest types of lung cancer, is an aggressive tumor that metastasizes early compared to other cancers and can quickly develop resistance to chemotherapy — ...
The rate of COVID-related intensive care unit (ICU) admissions was 9.2 per 1,000 person-years among patients who received a monovalent booster and 13.3 per 1,000 person-years for patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results